Science,
Politics and the Pharmaceutical Industry:
Controversy
and Bias in Drug Regulation
by John Abraham
The drug industry is major worldwide conglomerate
of intertwined business interests. The information in this book is integral
to an accurate understanding of what is going on today under the names
of "big business", "finance" and "monopolistic capitalism". Too often the
interests of "business" supersede the interests of the public. This is
true in all aspects of the pharmaceutical industry including psychiatry,
cancer, AIDs and more.
Reviews
Booknews, Inc., April 1, 1996
Of the myriad of issues surrounding the
testing and regulation of medicine, focuses on whether and how bias may
influence the scientific processes of evaluating the safety and effectiveness
of new drugs. Finds that corporate bias is indeed a significant social
and political problem both in Britain and the US, often compromising the
best interests of patients who take drugs that are either unsafe or ineffective
or both. Demonstrates the scope and depth of bias from individuals to institutions
and from animal testing to marketing claims. Annotation c. by Book News,
Inc., Portland, Or.
|
